Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
D000111:Acetylcysteine / Q000008:administration & dosage / Q000627:therapeutic use*; D000230:Adenocarcinoma / Q000188:drug therapy; D000284:Administration, Oral; D002277:Carcinoma / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000627:therapeutic use*; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D010865:Pilot Projects
D003520:Cyclophosphamide; D007069:Ifosfamide; D000111:Acetylcysteine